RxDoctor Payments Data

Jennifer Thomas

Adult Health · Dennison, OHNPI 1265663512

Payments from drug & device makers

$578in general payments, 2019–2025

Across 13 payments — averaging $44.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lucid Diagnostics Inc.$125
  • Novo Nordisk$109
  • Amgen$92
  • Biohaven Pharmaceutical Holding Company Ltd.$66
  • Edwards Lifesciences$60
  • GSK$52
  • plus $75 from 4 others

What the payments were for

  • Food & beverage$56698%
  • Education$122%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$578 in reported general payments places this provider in the 60th percentile of 1,184 adult health providers in Ohio.

See all adult health providers in Ohio

Medicare billing

Part B allowed, 2024
$5,493
Medicare patients
36
Services billed
142

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide77$89,681
EliquisApixaban49$49,374
JardianceEmpagliflozin70$46,712
OzempicSemaglutide50$45,475
JanuviaSitagliptin Phosphate39$30,678
Bydureon BciseExenatide Microspheres24$28,306
XareltoRivaroxaban51$27,549
Spiriva RespimatTiotropium Bromide31$19,481
VraylarCariprazine Hcl11$16,000
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$14,236
Combivent RespimatIpratropium/Albuterol Sulfate25$13,520
Lantus SolostarInsulin Glargine,hum.Rec.Anlog84$11,554
FarxigaDapagliflozin Propanediol31$9,976
MyrbetriqMirabegron13$6,190
Humalog Kwikpen U-100Insulin Lispro27$3,713

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$12$89,68177 claims
Novo NordiskOzempic$109$45,47550 claims
MerckJanuvia$19$30,67839 claims
AbbVieVraylar, Armour Thyroid$23$17,15922 claims
GSKTrelegy Ellipta$52$14,23622 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,184 adult health providers in Ohio.

Other adult health in Dennison

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →